Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The popular bed manager had often discussed her weight loss attempts with close friends, but the emergence of new weight-loss ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...